ArticlePloS one2010

Cancer cells acquire mitotic drug resistance properties through beta I-tubulin mutations and alterations in the expression of beta-tubulin isotypes.

Chun Hei Antonio Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.